Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,563 | 22,755 | 11,899 | 13,097 | 10,830 |
| Marketable Securities | 60,109 | 69,374 | 41,413 | 49,677 | 60,406 |
| Receivables | 61 | 140 | 170 | 204 | 163 |
| TOTAL | $80,398 | $94,236 | $54,684 | $64,382 | $73,289 |
| Non-Current Assets | |||||
| PPE Net | 7,998 | 8,447 | 9,093 | 9,539 | 9,985 |
| Intangibles | 33,305 | 33,597 | 33,888 | 34,179 | 34,835 |
| Other Non-Current Assets | 428 | 460 | 329 | 348 | 367 |
| TOTAL | $41,731 | $42,504 | $43,310 | $44,066 | $45,187 |
| Total Assets | $122,129 | $136,740 | $97,994 | $108,448 | $118,476 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,629 | 5,294 | 6,136 | 4,091 | 5,479 |
| Accounts payable and accrued liabilities | 395 | 535 | 935 | 457 | 514 |
| Accrued Expenses | 6,555 | 6,359 | 7,008 | 5,966 | 4,416 |
| Other current liabilities | N/A | 358 | 219 | 264 | N/A |
| TOTAL | $12,579 | $12,546 | $14,298 | $10,778 | $10,409 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,608 | 9,890 | 9,008 | 11,015 | 10,068 |
| Other Non-Current Liabilities | 6,394 | 6,418 | 5,966 | 5,981 | 5,994 |
| TOTAL | $15,002 | $16,308 | $14,974 | $16,996 | $16,062 |
| Total Liabilities | $27,581 | $28,854 | $29,272 | $27,774 | $26,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,955 | 3,918 | 3,813 | 2,945 | 2,945 |
| Common Shares | 59 | 59 | 44 | 44 | 44 |
| Retained earnings | -232,295 | -218,522 | -205,006 | -192,274 | -180,502 |
| Other shareholders' equity | 2,722 | 2,762 | 2,652 | 2,654 | 2,774 |
| TOTAL | $94,548 | $107,886 | $68,722 | $80,674 | $92,005 |
| Total Liabilities And Equity | $122,129 | $136,740 | $97,994 | $108,448 | $118,476 |